LEITNER LARRY 4

4 · HYPERTENSION DIAGNOSTICS INC /MN · Filed Aug 10, 2004

Form 4

Period: 2004-08-06

Director

Transactions

Conversion
Common Stock
2004-08-06$0.17/sh+203,559$34,605→ 203,559 total
Conversion
Common Stock Warrant (right to buy)
2004-08-06$0.17/sh−203,559$34,605→ 203,559 total
Exercise: $0.17Exp: 2004-11-09→ Common Stock (407,117 underlying)
Conversion
Series A Preferred Stock Warrant (right to buy)
2004-08-06$2.04/sh−12,800$26,112→ 12,800 total
Exercise: $2.04Exp: 2004-11-09→ Series A Preferred Stock (25,600 underlying)
Conversion
Series A Preferred Stock
2004-08-06$2.04/sh+12,800$26,112→ 12,800 total
Exercise: $2.04→ Common Stock (12,800 underlying)

Holdings

Common Stock Warrant (right to buy)
→ Common Stock (284,982 underlying)
284,982
Series A Preferred Stock Warrant (right to buy)
→ Series A Preferred Stock (17,920 underlying)
17,920
Common Stock
627,117
Series A Preferred Stock
→ Common Stock (25,600 underlying)
25,600
Common Stock Warrant (right to buy)
→ Common Stock (325,694 underlying)
325,694
Options (right to buy)
→ Common Stock (300,000 underlying)
300,000
Series A Preferred Stock Warrant (right to buy)
→ Series A Preferred Stock (20,480 underlying)
20,480

Footnotes (5)

[F1]Previously reported.
[F2]The purchase represents reporting person's exercise of the issuer's A-1 Preferred Stock Warrant and A-2 Common Stock Warrant.
[F3]See Table I.
[F4]Expiration date extended to November 9, 2004; shares issued on August 6, 2004.
[F5]Not applicable.

Documents

1 file